State Street's fee revenue has risen at a decent clip. Read why STT's business model should appeal to the more conservative ...

Discover if PDT suits your portfolio: 7.57% yield with monthly payouts, utility-heavy focus, and leverage risks.

Drew Pettit, U.S. Equity Strategist at Citi Research, says markets may overlook geopolitical shocks unless oil prices stay ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $101.52, a high estimate of $150.00, and a low estimate of $59.00. This current average has increased by 11 ...

China’s rare earth export crackdown is rattling the EV sector. With supply chains under stress, should investors reassess ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $20.5, a high estimate of $36.00 ...

How do you define a “better” exchange traded funds (ETF) for passive income investors? You might prefer an ETF with an ...

Palantir and Snowflake (NYSE: SNOW) are both high-growth software companies. Palantir stock has been a stellar performer over the past twelve months, rising by over 500%, compared to Snowflake, which ...

Going forward, Celltrion is expected to continue its current strategy, aiming to have a total of 23 biosimilar products by 2030, covering therapeutic areas such as immunology and oncology. Leveraging ...

Healthcare company Surgery Partners (NASDAQ:SGRY) in Q1 CY2025, as sales rose 8.2% year on year to $776 million. Its non-GAAP ...

NSDL's IPO is poised for launch with key shareholders like IDBI Bank reducing stakes. Stay updated on this crucial ...